• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of the host factor which is important for ovarian cancer dissemination

Research Project

Project/Area Number 23890100
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Obstetrics and gynecology
Research InstitutionOsaka University

Principal Investigator

HASHIMOTO Kae  大阪大学, 医学系研究科, 助教 (90612078)

Project Period (FY) 2011 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords卵巣癌 / 腹膜播種 / SDF-1
Research Abstract

This study was focused on the effect of SDF-1 on the ovarian cancer peritoneal dissemination. Stromal cell derived factor-1 (SDF-1) increased in the ascites of ovarian cancer model mice. SDF-1 promoted adhesion and invasion of ovarian cancer cell lines in vitro. Immunostaining showed SDF-1 was secreted from vascular pericytes or fibroblasts and tumor of TOV21G cell line. SDF-1 neutralizing antibody delayed tumor growth of advanced ovarian cancer model mice and prolonged survival.

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • Research Products

    (6 results)

All 2012

All Journal Article (1 results) Presentation (5 results)

  • [Journal Article] Low-dose metronomic oral dosing of a prodrug of Gemcitabine (LY2334737) causes anti-tumor effects in the absence of inhibition of systemic vasculogenesis.2012

    • Author(s)
      Francia G, Shaked Y, Hashimoto K, Sun J, Yin M, Cesta C, Xu P, Man S, Hackl C, Stewart J, Uhlik M, Dantzig A. H, Foster S, Kerbel R. S.
    • Journal Title

      Mol Cancer Ther

      Volume: 11 Pages: 680-689

    • Related Report
      2012 Final Research Report
  • [Presentation] 上皮性卵巣癌におけるmTOR complex 2 (mTORC2) の発現とその臨床的意義の検討2012

    • Author(s)
      久松武志, 馬淵誠士, 河野まひる, 橋本香映, 磯部晶, 澤田健二郎, 木村正
    • Organizer
      第52回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      東京
    • Year and Date
      2012-07-19
    • Related Report
      2012 Annual Research Report 2012 Final Research Report
  • [Presentation] 上皮性卵巣癌における mTOR complex 2 (mTORC2) の発現とその臨床的意義の検討2012

    • Author(s)
      久松武志, 馬淵誠士, 河野まひる, 橋本香映, 磯部晶, 澤田健二郎, 木村正
    • Organizer
      第64回日本産科婦人科学会学術講演会
    • Place of Presentation
      兵庫
    • Year and Date
      2012-04-14
    • Related Report
      2012 Final Research Report
  • [Presentation] 卵巣癌組織における Integrin α5 の発現が予後に与える影響の解析2012

    • Author(s)
      大八木知史, 澤田健二郎, 木瀬康人, 橋本香映, 馬淵誠士, 上浦祥司, 木村正
    • Organizer
      第64回日本産科婦人科学会学術講演会
    • Place of Presentation
      兵庫
    • Year and Date
      2012-04-14
    • Related Report
      2012 Final Research Report
  • [Presentation] 卵巣癌癌性腹膜炎モデルにおける新規低分子 IKK 阻害剤(IMD-0540)の有効性の検討2012

    • Author(s)
      橋本香映, 澤田健二郎, 磯部晶, 大八木知史, 木瀬康人, 馬淵誠士, 木村正
    • Organizer
      第64回日本産科婦人科学会学術講演会
    • Place of Presentation
      兵庫
    • Year and Date
      2012-04-14
    • Related Report
      2012 Final Research Report
  • [Presentation] 上皮性卵巣癌におけるmTOR complex 2 (mTORC2) の発現とその臨床的意義の検討2012

    • Author(s)
      久松武志、馬淵誠士、河野まひる、橋本香映、磯部晶、澤田健二郎、木村正
    • Organizer
      第64回日本産科婦人科学会学術講演会
    • Place of Presentation
      兵庫
    • Related Report
      2012 Annual Research Report

URL: 

Published: 2011-09-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi